This is obviously a very important question for us. There are a couple of facts that are staring us in the face here. One is that we are a leader in the OECD on public support for R and D, and we're pretty successful in terms of our results, especially in terms of basic science.
But where we're not very successful is in business support for R and D. In fact, at best, we're in the middle of the pack.
This is, I believe, one of the reasons that the government has decided to undertake this R and D review, because we do spend a lot of money in this area, in two parts. One bucket is on the tax support side, the scientific research and experimental development—or SR and ED—tax credit. The other part is direct support, some of which is for basic science but some of which is directly aimed at R and D.
We have some areas that, we hear from stakeholders, work really well. For example, IRAP is one that stakeholders feel is very successful. We have increased our support in other areas, but this is something that the government wants to look at through the R and D review.